VRBCF
Virbac SA
346.00
+0.00+0%
Dec 16, 4:00:00 PM EST

Upcoming Earnings 

Report date
-/-

Earnings Call Transcripts

This Quarter (Q4 '25)

No earnings call transcript available yet

Last Quarter (Q3 '25)

No earnings call transcript available

Key Stats

Market Cap
2.90B
P/E (TTM)
17.04
Basic EPS (TTM)
20.31
Dividend Yield
0%

About 

Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific. The company offers a range of vaccines, antibiotics, parasiticides, and anti-inflammatory drugs, as well as dermatology, dental, specialty, diagnosis, nutrition, petfood, and pharmaceutical products. It serves veterinarians, farmers, and pet owners. The company was founded in 1968 and is headquartered in Carros, France.

CEO
Mr. Habib Ramdani
IPO
4/17/2013
Employees
6,365
Sector
Healthcare
Industry
Drug Manufacturers - General